Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Non-cash Items (2023 - 2025)

Historic Non-cash Items for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $228000.0.

  • BioLineRx's Non-cash Items rose 10569.57% to $228000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year decrease of 147.77%. This contributed to the annual value of -$34.7 million for FY2024, which is 19117.51% down from last year.
  • According to the latest figures from Q3 2025, BioLineRx's Non-cash Items is $228000.0, which was up 10569.57% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Non-cash Items registered a high of $18.9 million during Q4 2023, and its lowest value of -$13.4 million during Q1 2024.
  • Moreover, its 3-year median value for Non-cash Items was $228000.0 (2025), whereas its average is -$157272.7.
  • As far as peak fluctuations go, BioLineRx's Non-cash Items crashed by 42351.66% in 2024, and later skyrocketed by 12036.74% in 2025.
  • BioLineRx's Non-cash Items (Quarter) stood at $18.9 million in 2023, then crashed by 128.73% to -$5.4 million in 2024, then soared by 104.2% to $228000.0 in 2025.
  • Its Non-cash Items was $228000.0 in Q3 2025, compared to $2.4 million in Q2 2025 and -$7.7 million in Q1 2025.